Skip to main content


Fig. 3 | Stem Cell Research & Therapy

Fig. 3

From: Human bone marrow-derived and umbilical cord-derived mesenchymal stem cells for alleviating neuropathic pain in a spinal cord injury model

Fig. 3

Luxol fast blue staining for assessment of cavity size in control (a), sham (b), spinal cord injured (SCI) (c), vehicle-treated (d), human bone marrow-derived mesenchymal stem cell (BM-MSC) (e) and umbilical cord-derived mesenchymal stem cell (UC-MSC) (f) animals. Transplantation of human BM-MSCs and UC-MSCs resulted in significantly decreased cavity size (g). Original magnification in af, ×20. Data are expressed as means ± SEM (n = 3 in each group). *p < 0.001, versus SCI group

Back to article page